Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2163 to 2212 of 3228 in total
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1
\def\wcA{0.16666666666667\textwidth} \def\wcB{0.16666666666667\textwidth} \def\wcC{0.16666666666667\textwidth} \def\wcD{0.16666666666667\textwidth} \def\wcE{0.16666666666667\textwidth} \begin{longtable}{|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 2163\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent mitogen-activated protein kinase kinase kinase 6 (ec 2.7.1.-). [source:swissprot;acc:o95382]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 215.925\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 214.481\vspace{3pt}}}&\multirow{12}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.00673\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2164\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent signal-induced proliferation-associated 1-like 1. [source:refseq;acc:nm\_015556]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2165\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ribosomal protein s6 kinase alpha 1 (ec 2.7.1.37) (s6k-alpha 1) (90 kda ribosomal protein s6 kinase 1) (p90-rsk 1) (ribosomal s6 kinase 1) (rsk-1) (pp90rsk1). [source:swissprot;acc:q15418]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2166\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent atp-binding cassette, sub-family d, member 3 (70 kda peroxisomal membrane protein) (pmp70). [source:swissprot;acc:p28288]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2167\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent glutaryl-coa dehydrogenase, mitochondrial precursor (ec 1.3.99.7) (gcd). [source:swissprot;acc:q92947]\vspace{3pt}}&&&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 2168\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent mitogen-activated protein kinase 1 (ec 2.7.1.37) (extracellular signal-regulated kinase 2) (erk-2) (mitogen-activated protein kinase 2) (map kinase 2) (mapk 2) (p42-mapk) (ert1). [source:swissprot;acc:p28482]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 215.929\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 214.486\vspace{3pt}}&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 2169\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent histidine ammonia-lyase (ec 4.3.1.3) (histidase). [source:swissprot;acc:p42357]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 215.925\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 214.481\vspace{3pt}}}&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2170\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ribosomal protein s6 kinase alpha 6 (ec 2.7.1.37) (s6k-alpha 6) (90 kda ribosomal protein s6 kinase 6) (p90-rsk 6) (ribosomal s6 kinase 4) (rsk-4) (pp90rsk4). [source:swissprot;acc:q9uk32]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2171\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ribosomal protein s6 kinase alpha 2 (ec 2.7.1.37) (s6k-alpha 2) (90 kda ribosomal protein s6 kinase 2) (p90-rsk 2) (ribosomal s6 kinase 3) (rsk-3) (pp90rsk3). [source:swissprot;acc:q15349]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2172\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent calcium/calmodulin-dependent protein kinase type ii alpha chain (ec 2.7.1.123) (cam-kinase ii alpha chain) (cam kinase ii alpha subunit) (camk-ii alpha subunit). [source:swissprot;acc:q9uqm7]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2173\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent calcium/calmodulin-dependent protein kinase type ii beta chain (ec 2.7.1.123) (cam-kinase ii beta chain) (cam kinase ii beta subunit) (camk-ii beta subunit). [source:swissprot;acc:q13554]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2174\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent mitogen-activated protein kinase kinase kinase 5 (ec 2.7.1.-) (mapk/erk kinase kinase 5) (mek kinase 5) (mekk 5) (apoptosis signal- regulating kinase 1) (ask-1). [source:swissprot;acc:q99683]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2175\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 26s proteasome non-atpase regulatory subunit 2 (26s proteasome regulatory subunit s2) (26s proteasome subunit p97) (tumor necrosis factor type 1 receptor associated protein 2) (55.11 protein). [source:swissprot;acc:q13200]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 210.209\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 208.808\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00671\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2176\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent serine/threonine-protein kinase plk (ec 2.7.1.-) (plk-1) (serine- threonine protein kinase 13) (stpk13). [source:swissprot;acc:p53350]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 218.089\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 216.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00669\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2177\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent peroxisomal membrane protein 2 (22 kda peroxisomal membrane protein). [source:swissprot;acc:q9nr77]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 210.961\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 209.563\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.00667\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2178\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent heat shock-related 70 kda protein 2 (heat shock 70 kda protein 2). [source:swissprot;acc:p54652]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2179\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent heat shock 70 kda protein 1 (hsp70.1) (hsp70-1/hsp70-2). [source:swissprot;acc:p08107]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2180\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent heat shock cognate 71 kda protein. [source:swissprot;acc:p11142]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2181\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent calreticulin precursor (crp55) (calregulin) (hacbp) (erp60). [source:swissprot;acc:p27797]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 227.117\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 225.62\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.00664\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 2182\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent twinkle; likely ortholog of mouse t7 gp4-like protein with intramitochondrial nucleoid localization. [source:refseq;acc:nm\_021830]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 218.062\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 216.624\vspace{3pt}}}&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2183\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent rabaptin, rab gtpase binding effector protein 1; rabaptin-5; neurocrescin. [source:refseq;acc:nm\_004703]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2184\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent suppressor of var1, 3-like 1. [source:refseq;acc:nm\_003171]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 211.713\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 210.318\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.00663\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2185\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent bag-family molecular chaperone regulator-1 (bcl-2 binding athanogene- 1) (bag-1) (glucocorticoid receptor-associated protein rap46). [source:swissprot;acc:q99933]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2186\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent glycogen synthase kinase-3 alpha (ec 2.7.1.37) (gsk-3 alpha). [source:swissprot;acc:p49840]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2187\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent glycogen synthase kinase-3 beta (ec 2.7.1.37) (gsk-3 beta). [source:swissprot;acc:p49841]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2188\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent protein disulfide isomerase precursor (pdi) (ec 5.3.4.1) (prolyl 4- hydroxylase beta subunit) (cellular thyroid hormone binding protein) (p55). [source:swissprot;acc:p07237]\vspace{3pt}}&\multirow{9}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 209.54\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 208.162\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.00662\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2189\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 3-hydroxyanthranilate 3,4-dioxygenase (ec 1.13.11.6) (3-hao) (3-hydroxyanthranilic acid dioxygenase) (3-hydroxyanthranilate oxygenase). [source:swissprot;acc:p46952]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2190\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent zinc finger protein-like 1; zinc-finger protein in men1 region. [source:refseq;acc:nm\_006782]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2191\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent hus1 checkpoint protein; hus1 (s. pombe) checkpoint homolog; hus1+-like protein. [source:refseq;acc:nm\_004507]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2192\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent hyaluronan binding protein 4; intracellular antigen detected by monoclonal antibody ki-1; intracellular hyaluronan-binding protein; chromodomain helicase dna binding protein 3 interacting protein. [source:refseq;acc:nm\_014282]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2193\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent prolyl 4-hydroxylase alpha-1 subunit precursor (ec 1.14.11.2) (4-ph alpha-1) (procollagen-proline,2-oxoglutarate-4-dioxygenase alpha-1 subunit). [source:swissprot;acc:p13674]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2194\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent homeobox prospero-like protein prox1 (prox 1). [source:swissprot;acc:q92786]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2195\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent rad1 homolog isoform 1; exonuclease homolog rad1; cell cycle checkpoint protein rad1 a/b; rad1-like protein; cell cycle checkpoint protein hrad1; dna repair exonuclease (rec1); dna repair protein rad1; rad1-like dna damage checkpoint protein. [source:refseq;acc:nm\_002853]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2196\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent prolyl 4-hydroxylase alpha-2 subunit precursor (ec 1.14.11.2) (4-ph alpha-2) (procollagen-proline,2-oxoglutarate-4-dioxygenase alpha-2 subunit). [source:swissprot;acc:o15460]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2197\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ubiquinone biosynthesis monooxgenase coq6 (ec 1.14.13.-) (cgi-10). [source:swissprot;acc:q9y2z9]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 193.787\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 195.064\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.00659\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2198\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent kynurenine 3-monooxygenase (kynurenine 3-hydroxylase). [source:refseq;acc:nm\_003679]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2199\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent squalene monooxygenase (ec 1.14.99.7) (squalene epoxidase) (se). [source:swissprot;acc:q14534]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2200\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent insulin gene enhancer protein isl-2 (islet-2). [source:swissprot;acc:q96a47]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 196.748\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 195.466\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00656\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2201\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent p47 protein isoform a. [source:refseq;acc:nm\_016143]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 213.642\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.254\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00654\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2202\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent tumor susceptibility gene 101 protein. [source:swissprot;acc:q99816]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 195.97\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 194.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00652\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2203\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent symplekin. [source:swissprot;acc:q92797]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 162.741\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 163.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00651\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2204\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ruvb-like 2 (ec 3.6.1.-) (48-kda tata box-binding protein-interacting protein) (48-kda tbp-interacting protein) (tip49b) (repressing pontin 52) (reptin 52) (51 kda erythrocyte cytosolic protein) (ecp-51) (tip60-associated protein 54-beta) (tap54-beta) (cgi-46). [source:swissprot;acc:q9y230]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 219.377\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 220.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00649\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2205\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 60s ribosomal protein l22 (epstein-barr virus small rna associated protein) (eber associated protein) (eap) (heparin binding protein hbp15). [source:swissprot;acc:p35268]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 199.129\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 200.413\vspace{3pt}}&\multirow{7}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.00645\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 2206\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent transitional endoplasmic reticulum atpase (ter atpase) (15s mg(2+)- atpase p97 subunit) (valosin containing protein) (vcp) [contains: valosin]. [source:swissprot;acc:p55072]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 215.571\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 214.19\vspace{3pt}}&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 2207\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent sin3 associated polypeptide p30; sin3-associated polypeptide, 30kd. [source:refseq;acc:nm\_003864]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 199.129\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 200.413\vspace{3pt}}}&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2208\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent clathrin coat assembly protein ap50 (clathrin coat associated protein ap50) (plasma membrane adaptor ap-2 50 kda protein) (ha2 50 kda subunit) (clathrin assembly protein complex 2 medium chain) (ap-2 mu 2 chain). [source:swissprot;acc:p20172]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2209\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent atp-binding cassette, sub-family c, member 10; multidrug resistance-associated protein 7. [source:refseq;acc:nm\_033450]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2210\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent lysosomal alpha-mannosidase precursor (ec 3.2.1.24) (mannosidase, alpha b) (lysosomal acid alpha-mannosidase) (laman) (mannosidase alpha class 2b member 1). [source:swissprot;acc:o00754]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2211\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent rna polymerase i transcription factor rrn3. [source:refseq;acc:nm\_018427]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2212\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 28s ribosomal protein s16, mitochondrial precursor (mrp-s16) (cgi- 132). [source:swissprot;acc:q9y3d3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 224.411\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 225.854\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00643\vspace{3pt}}\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/